Gadodiamide - PDFSEARCH.IO - Document Search Engine

Gadodiamide
Results: 44

#	Item
21	[removed]Gadobendate Clinical PREA Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Gadopentetic acid Gadodiamide Magnetic resonance imaging MRI contrast agent Nephrogenic systemic fibrosis Gadobenic acid Chemistry Matter Medicine
22	Pediatric Focused Safety Review: MultiHance Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Boxed warning Food and Drug Administration Gadobenic acid Gadopentetic acid Gadodiamide Chemistry Matter Medicine
23	[removed]Gadobutrol Clinical PREA Add to Reading List Source URL: www.fda.gov Language: English Gadopentetic acid Gadolinium MRI contrast agent Magnetic resonance imaging Gadodiamide Food and Drug Administration Brain tumor Nephrogenic systemic fibrosis Chemistry Medicine Matter
24	Department of Health and Human Services Public Health Service Food and Drug Administration Add to Reading List Source URL: www.fda.gov Language: English Medicine Matter Medical terms Adverse Event Reporting System Norfloxacin Gadodiamide Boxed warning Adverse effect Gadolinium Chemistry Piperazines Food and Drug Administration
25	The recommended dose of Gadavist is 0.1 mL/kg body weight (0.1 mmol/kg), administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second. Flush the intravenous cannula with physiological saline Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:38:58 Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Radiocontrast agent Ketorolac Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Gadodiamide
26	Multihance (gadobenate dimeglumine) injection label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 13:20:36 Gadodiamide Nephrogenic systemic fibrosis Gadolinium Magnetic resonance imaging Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Medicine
27	Ablavar (gadofosveset trisodium) solution label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 10:25:06 Nephrogenic systemic fibrosis Nephrology Gadolinium Magnetic resonance imaging MRI contrast agent Gadodiamide Chemistry Matter Medicine
28	EU PSUR WORK SHARING SUMMARY ASSESSMENT REPORT DK/H/PSUR[removed]P-RMS: Invented name of the medicinal Add to Reading List Source URL: www.hma.eu Language: English - Date: 2014-03-04 09:54:09 Magnetic resonance imaging Chemistry Nephrogenic systemic fibrosis Bioavailability Fibrosis Medicine Gadodiamide Health
29	PDF Document Add to Reading List Source URL: www.hma.eu Language: English - Date: 2014-03-04 10:12:08 Gadolinium Traceability Syringe Label Gadofosveset Gadodiamide Chemistry Matter Technology
30	ONC-2R-OSLO WARING: NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with: . acute or chronic severe renal insufficiency Cglomerular fi Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:43:12 Gadolinium Gadopentetic acid Nephrogenic systemic fibrosis Magnetic resonance imaging MRI contrast agent Chemistry Matter Gadodiamide

UPDATE